Literature DB >> 23103154

Improving the osteogenic potential of BMP-2 with hyaluronic acid hydrogel modified with integrin-specific fibronectin fragment.

Marta Kisiel1, Mikaël M Martino, Manuela Ventura, Jeffrey A Hubbell, Jöns Hilborn, Dmitri A Ossipov.   

Abstract

While human bone morphogenetic protein-2 (rhBMP-2) is a promising growth factor for bone regeneration, its clinical efficacy has recently shown to be below expectation. In order to improve the clinical translation of rhBMP-2, there exists strong motivation to engineer better delivery systems. Hyaluronic acid (HA) hydrogel is a suitable carrier for the delivery of rhBMP-2, but a major limitation of this scaffold is its low cell adhesive properties. In this study, we have determined whether covalent grafting of an integrin-specific ligands into HA hydrogel could improve cell attachment and further enhance the osteogenic potential of rhBMP-2. A structurally stabilized fibronectin (FN) fragment containing the major integrin-binding domain of full-length FN (FN III9*-10) was engineered, in order to be incorporated into HA hydrogel. Compared to non-functionalized HA hydrogel, HA-FN hydrogel remarkably improved the capacity of the material to support mesenchymal stem cell attachment and spreading. In an ectopic bone formation model in the rat, delivery of rhBMP-2 with HA-FN hydrogel resulted in the formation of twice as much bone with better organization of collagen fibers compared to delivering the growth factor in non-functionalized HA hydrogel. This engineered hydrogel carrier for rhBMP-2 can be relevant in clinical bone repair.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103154     DOI: 10.1016/j.biomaterials.2012.10.015

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  26 in total

Review 1.  Biomimetic polymer scaffolds to promote stem cell-mediated osteogenesis.

Authors:  Eunkyung Ko; Seung-Woo Cho
Journal:  Int J Stem Cells       Date:  2013-11       Impact factor: 2.500

Review 2.  Growth factor-eluting technologies for bone tissue engineering.

Authors:  Ethan Nyberg; Christina Holmes; Timothy Witham; Warren L Grayson
Journal:  Drug Deliv Transl Res       Date:  2016-04       Impact factor: 4.617

Review 3.  Scaffold design for bone regeneration.

Authors:  Liliana Polo-Corrales; Magda Latorre-Esteves; Jaime E Ramirez-Vick
Journal:  J Nanosci Nanotechnol       Date:  2014-01

Review 4.  Engineering Stem and Stromal Cell Therapies for Musculoskeletal Tissue Repair.

Authors:  Claudia Loebel; Jason A Burdick
Journal:  Cell Stem Cell       Date:  2018-02-08       Impact factor: 24.633

Review 5.  Engineering synthetic hydrogel microenvironments to instruct stem cells.

Authors:  Murat Guvendiren; Jason A Burdick
Journal:  Curr Opin Biotechnol       Date:  2013-03-29       Impact factor: 9.740

6.  Novel mineralized heparin-gelatin nanoparticles for potential application in tissue engineering of bone.

Authors:  Yuan Yang; Haihao Tang; Alexander Köwitsch; Karsten Mäder; Gerd Hause; Joachim Ulrich; Thomas Groth
Journal:  J Mater Sci Mater Med       Date:  2013-12-06       Impact factor: 3.896

Review 7.  Biomechanics and mechanobiology in functional tissue engineering.

Authors:  Farshid Guilak; David L Butler; Steven A Goldstein; Frank P T Baaijens
Journal:  J Biomech       Date:  2014-04-26       Impact factor: 2.712

8.  BMP2 cross-linked by transglutaminase 2 to collagen-plla scaffold promotes osteogenic differentiation in mesenchymal stem cells.

Authors:  Kelly E Beazley; Maria Nurminskaya
Journal:  Biotechnol Lett       Date:  2014-06-15       Impact factor: 2.461

Review 9.  Design of cell-matrix interactions in hyaluronic acid hydrogel scaffolds.

Authors:  Jonathan Lam; Norman F Truong; Tatiana Segura
Journal:  Acta Biomater       Date:  2013-07-27       Impact factor: 8.947

Review 10.  Utilizing Fibronectin Integrin-Binding Specificity to Control Cellular Responses.

Authors:  Haylee Bachman; John Nicosia; Marilyn Dysart; Thomas H Barker
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-08-01       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.